[Skip to Navigation]
Views 127
Citations 0
Comment & Response
November 15, 2021

Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures—Reply

Author Affiliations
  • 1Department of Neurology, Weill Institute for Neuroscience, University of California, San Francisco, San Francisco
  • 2Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California, San Francisco, San Francisco
  • 3Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco
  • 4Department of Pediatrics, University of Michigan, Ann Arbor
JAMA Neurol. Published online November 15, 2021. doi:10.1001/jamaneurol.2021.4112
Add or change institution
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words